Combined Oral Contraceptives and Sexual Function in Women-a Double-Blind, Randomized, Placebo-Controlled Trial

Area of Science:

• Reproductive Health
• Pharmacology
• Clinical Trials

Background:

• Limited understanding exists regarding the impact of oral contraceptives on female sexual function.
• Investigating the potential link between oral contraceptive use and sexual health is crucial for informed patient care.

Purpose of the Study:

• To ascertain a causal relationship between oral contraceptives and changes in female sexuality.
• To test the hypothesis that a commonly used oral contraceptive impairs sexual function.

Main Methods:

• A rigorous double-blind, randomized, placebo-controlled trial was conducted.
• 340 healthy women aged 18-35 received either a combined oral contraceptive or a placebo for three months.
• The Profile of Female Sexual Function (PFSF) was the primary outcome measure.

Main Results:

• No significant difference in overall sexual function was observed between the oral contraceptive and placebo groups.
• Significant reductions were noted in the PFSF domains of desire, arousal, and pleasure for the oral contraceptive group compared to placebo.
• Secondary outcomes, including sexual activity frequency and personal distress, showed no significant differences between groups.

Conclusions:

• A levonorgestrel-containing oral contraceptive did not adversely affect overall female sexual function.
• Specific domains of sexual function, namely desire, arousal, and pleasure, were negatively impacted by the oral contraceptive.
• Findings suggest a nuanced effect of oral contraceptives on female sexuality, impacting specific aspects rather than overall function.